MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-28, JNJ made $94,193M in revenue. $26,804M in net income. Net profit margin of 28.46%.

Income Overview

Revenue
$94,193M
Net Income
$26,804M
Net Profit Margin
28.46%
EPS
$11.03
Unit: Million (M) dollars
Revenue Breakdown
    • Innovative Medicine
    • Med Tech
Revenue Breakdown
    • US
    • Europe
    • Asia Pacific Africa
    • Western Hemisphere Excluding US

Unit: Million (M) dollars (except for numbers of shares and EPS)
Income Statement
2025-12-28
2024-12-29
2023-12-31
2023-01-01
Sales to customers
94,193 88,821 85,159 94,943
Cost of products sold
30,256 27,471 26,553 31,089
Gross profit
63,937 61,350 58,606 63,854
Selling, marketing and administrative expenses
23,676 22,869 21,512 24,765
Research and development expense
14,665 17,232 15,085 14,603
In-process research and development (note 5)
---783
In-process research and development impairments
81 211 313 -
Interest income
1,056 1,332 1,261 490
Interest expense, net of portion capitalized
971 755 772 276
Other (income) expense, net
7,209 -4,694 -6,634 -1,871
Restructuring
228 234 489 321
Earnings before provision for taxes on income
32,581 16,687 15,062 21,725
Effective rate
5,777 2,621 1,736 3,784
Net earnings from continuing operations
26,804 14,066 13,326 -
Net earnings from discontinued operations
0 0 21,827 -
Net earnings
26,804 14,066 35,153 17,941
Basic (in dollars per share)
11.13 5.84 13.88 6.83
Basic (in shares)
2,407,400,000 2,407,300,000 2,533,500,000 2,625,200,000
Diluted (in dollars per share)
11.03 5.79 13.72 6.73
Diluted (in shares)
2,429,400,000 2,429,400,000 2,560,400,000 2,663,900,000
Unit: Million (M) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Med Tech$33,792M Innovative Medicine$60,401M Sales to customers$94,193M Other (income)expense, net$7,209M Interest income$1,056M Gross profit$63,937M Cost of products sold$30,256M Earnings beforeprovision for taxes on...$32,581M Restructuring$228M Interest expense, net ofportion capitalized$971M In-process research anddevelopment impairments$81M Research and developmentexpense$14,665M Selling, marketing andadministrative expenses$23,676M Net earnings fromcontinuing operations$26,804M Effective rate$5,777M Net earnings$26,804M

JNJ_BIG_BIG copy-svg

JOHNSON & JOHNSON (JNJ)

JNJ_BIG_BIG copy-svg

JOHNSON & JOHNSON (JNJ)